Industry Overview

Medical imaging phantom market was valued at $235.0 million in 2025 and is projected to reach $415.0 million by 2035, growing at a CAGR of 6.5% during the forecast period (2026-2035). The market has become an important segment within the medical imaging and healthcare technology industries. Medical imaging phantoms are specialised devices that simulate the physical and radiological properties of human tissues, enabling the calibration, testing, and quality assurance of diagnostic imaging systems. These devices are widely used to evaluate the performance of imaging equipment such as computed tomography (CT) scanners, magnetic resonance imaging (MRI) systems, ultrasound devices, and nuclear imaging systems, including PET and SPECT scanners. Imaging phantoms play a critical role in ensuring the accuracy, reliability, and safety of medical imaging procedures used for disease diagnosis and clinical research. The growth of the market is largely attributed to the increasing utilisation of advanced diagnostic imaging technologies across healthcare systems worldwide. Medical imaging has become an essential component of modern healthcare, supporting early disease detection, treatment planning, and clinical monitoring. Imaging modalities such as CT, MRI, and ultrasound are widely used across multiple medical specialties including oncology, cardiology, neurology, and orthopaedics. As healthcare providers increasingly rely on imaging technologies for accurate diagnosis, maintaining consistent image quality and equipment performance has become critically important.

Market Dynamics

Rising Prevalence of Chronic Diseases and Increasing Diagnostic Imaging Procedures

One of the primary drivers of the medical imaging phantom market is the growing prevalence of chronic diseases and the increasing number of diagnostic imaging procedures performed globally. Medical imaging technologies play a critical role in the early detection and monitoring of diseases such as cancer, cardiovascular disorders, and neurological conditions. According to the World Health Organisation (WHO), cancer accounted for nearly 10 million deaths globally in 2022, highlighting the increasing need for advanced diagnostic imaging technologies for early detection and treatment planning. Imaging modalities such as CT scans, MRI scans, and PET imaging are widely used to identify tumours, evaluate disease progression, and guide treatment strategies. The increasing demand for diagnostic imaging procedures directly contributes to the need for reliable quality assurance systems. Hospitals and diagnostic laboratories conduct routine testing and calibration of imaging equipment to ensure accurate diagnostic results. Medical imaging phantoms provide standardised testing platforms that allow technicians to evaluate system resolution, contrast sensitivity, and geometric accuracy. As healthcare systems expand diagnostic imaging capabilities to meet the growing burden of chronic diseases, the demand for imaging phantoms is expected to increase significantly.

Expansion of Healthcare Infrastructure and Medical Imaging Facilities

The expansion of healthcare infrastructure and the increasing number of imaging facilities globally represent another important factor driving the growth of the medical imaging phantom market. Governments and healthcare organisations are investing heavily in improving diagnostic capabilities and expanding medical imaging services to enhance patient care. According to the Organisation for Economic Co-operation and Development (OECD), the number of MRI examinations per 1,000 population has steadily increased across many developed healthcare systems over the past decade. These investments reflect the growing reliance on imaging technologies in modern healthcare systems.

As hospitals and diagnostic centres deploy new imaging systems, regular calibration and performance testing become essential to maintain diagnostic accuracy. Medical imaging phantoms enable healthcare facilities to perform quality control procedures and verify equipment performance before clinical use. Additionally, regulatory agencies and healthcare accreditation organisations require strict compliance with imaging quality standards, further increasing the adoption of phantom devices. As global healthcare infrastructure continues to expand and diagnostic imaging technologies become more widely available, the medical imaging phantom market is expected to experience sustained growth.

Market Segmentation

• Based on the type, the market is segmented into CT phantoms, MRI phantoms, ultrasound phantoms, X-ray and radiography phantoms, PET/SPECT, anthropomorphic phantoms.
• Based on the application, the market is segmented into hospitals, academic and research institutes, diagnostic and reference laboratories, medical device companies.

Hospitals: A High-Growth Segment

The hospitals segment is expected to represent one of the fastest-growing end-use industries in the medical imaging phantom market. Hospitals are the primary centres for diagnostic imaging services and rely extensively on imaging equipment to support patient diagnosis and treatment planning. Imaging technologies such as CT scanners, MRI systems, ultrasound machines, and nuclear imaging devices are widely used across multiple clinical departments, including oncology, cardiology, orthopaedics, and emergency medicine. These imaging systems require regular calibration and quality assurance testing to maintain optimal performance and ensure accurate diagnostic outcomes. Medical imaging phantoms play an essential role in hospital imaging departments by enabling technicians to evaluate image quality, measure system resolution, and verify geometric accuracy. These devices simulate human tissue characteristics and allow healthcare professionals to test imaging systems under controlled conditions. Hospitals perform routine quality control procedures using imaging phantoms to ensure compliance with regulatory standards and clinical safety requirements. According to the World Health Organisation, global healthcare systems are increasingly expanding diagnostic imaging services to improve disease detection and treatment planning. The growing number of hospital imaging departments and the increasing adoption of advanced imaging technologies are expected to drive the demand for medical imaging phantoms. As healthcare providers invest in high-performance imaging systems and expand diagnostic capabilities, hospitals will continue to represent a key end-use segment contributing to the growth of the medical imaging phantom market.

Regional Outlook

The global medical imaging phantom market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Leads the Global Medical Imaging Phantom Market

North America currently holds a significant share of the global medical imaging phantom market due to the presence of advanced healthcare infrastructure and the widespread adoption of diagnostic imaging technologies across the region. The United States represents one of the largest healthcare markets in the world and hosts a large number of hospitals, diagnostic imaging centres, and medical research institutions. The region also benefits from the strong presence of medical technology companies and imaging equipment manufacturers that continuously invest in research and development activities. The high adoption rate of advanced imaging technologies such as MRI, CT, and PET scanners contributes to the strong demand for imaging phantom devices used for equipment calibration and quality assurance. Additionally, regulatory agencies and healthcare accreditation organisations in North America emphasise strict quality standards for medical imaging systems, further supporting the adoption of imaging phantoms.

Market Players Outlook

The major companies operating in the global Medical Imaging include Sun Nuclear Corporation, Kyoto Kagaku Co., Ltd., Modus Medical Devices Inc., PTW-Freiburg GmbH, The Phantom Laboratory Inc., among others. These companies play a crucial role in the development and manufacturing of advanced semiconductor technologies used in computing, communication, and industrial applications. Leading semiconductor manufacturers are continuously investing in research and development activities to improve the processing performance, power efficiency, and system integration capabilities of logic devices. Key strategies adopted by these companies include the development of advanced semiconductor architectures, expansion of fabrication facilities, and collaboration with technology companies developing next-generation computing systems. Additionally, semiconductor manufacturers are focusing on designing specialised processors and programmable logic devices that support artificial intelligence, edge computing, and high-performance data processing applications.

Recent Developments

• In October 2025, PTW expanded its Beam scan product family with new water phantom models designed to meet the diverse needs of modern clinics. These new models offer tailored solutions for a variety of clinical environments, whether dealing with limited space, time constraints, or the need for mobile applications. By providing versatile and optimized options, PTW ensures that every clinic and user can benefit from precise and efficient dosimetry. The new Beam scan models are set to be available starting early 2026.

• In April 2025, Sun Nuclear Corporation acquired Oncospace, an AI-driven radiation oncology software provider, to strengthen its digital and quality assurance capabilities. The acquisition integrates AI and machine learning solutions for treatment planning optimization and predictive plan quality analysis. This strategic move enhances radiation therapy precision, efficiency, and overall patient treatment outcomes.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualised market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global medical imaging phantom market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.